About the Authors
- Aman P. Mann
-
Contributed equally to this work with: Aman P. Mann, Anoma Somasunderam
Affiliation Department of Nanomedicine and Biomedical Engineering, University of Texas Health Science Center at Houston, Houston, Texas, United States of America
- Anoma Somasunderam
-
Contributed equally to this work with: Aman P. Mann, Anoma Somasunderam
Affiliation Department of Nanomedicine and Biomedical Engineering, University of Texas Health Science Center at Houston, Houston, Texas, United States of America
- René Nieves-Alicea
-
Affiliation Department of Nanomedicine and Biomedical Engineering, University of Texas Health Science Center at Houston, Houston, Texas, United States of America
- Xin Li
-
Affiliation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas, United States of America
- Austin Hu
-
Affiliation Department of Biomedical Engineering, University of Texas Austin, Austin, Texas, United States of America
- Anil K. Sood
-
Affiliations Department of Gynecologic Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America, Department of Cancer Biology, University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America
- Mauro Ferrari
-
Affiliations Department of Nanomedicine and Biomedical Engineering, University of Texas Health Science Center at Houston, Houston, Texas, United States of America, Department of Biomedical Engineering, University of Texas Austin, Austin, Texas, United States of America, Department of Experimental Therapeutics, University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America, Department of Bioengineering, Rice University, Houston, Texas, United States of America
- David G. Gorenstein
-
Affiliation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas, United States of America
- Takemi Tanaka
-
* E-mail: Takemi.Tanaka@jefferson.edu
Affiliations Department of Nanomedicine and Biomedical Engineering, University of Texas Health Science Center at Houston, Houston, Texas, United States of America, Department of Biomedical Engineering, University of Texas Austin, Austin, Texas, United States of America, Department of Pharmaceutical Sciences, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America
Competing Interests
D.G. has financial interest in AM Biotechnologies and AptaMed Inc. A.M, A.S., D.G, and T.T are inventors on a patent on ESTA-1 in preparation. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: APM AS DG TT. Performed the experiments: APM AS XL AH TT. Analyzed the data: APM AS RNA TT. Contributed reagents/materials/analysis tools: AS MF. Wrote the paper: APM AS RNA TT.